SRVEX
Price
$26.55
Change
+$0.06 (+0.23%)
Updated
Jun 2 closing price
Net Assets
397.97M
VITSX
Price
$182.22
Change
+$0.44 (+0.24%)
Updated
Jun 2 closing price
Net Assets
2.2T
Interact to see
Advertisement

SRVEX vs VITSX

Header iconSRVEX vs VITSX Comparison
Open Charts SRVEX vs VITSXBanner chart's image
SRVEX vs VITSX Comparison Chart in %
View a ticker or compare two or three
VS
SRVEX vs. VITSX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SRVEX is a Buy and VITSX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VITSX has more cash in the bank: 2.2T vs. SRVEX (398M). VITSX pays higher dividends than SRVEX: VITSX (1.01) vs SRVEX (0.21). SRVEX was incepted earlier than VITSX: SRVEX (37 years) vs VITSX (29 years). SRVEX (1.05) is less costly to investors than VITSX (0.03). SRVEX is a more actively managed with annual turnover of: 92.00 vs. VITSX (3.00). SRVEX has a lower initial minimum investment than VITSX: SRVEX (2500) vs VITSX (5000000). VITSX annual gain was more profitable for investors over the last year : 28.25 vs. SRVEX (19.99). VITSX return over 5 years is better than : 72.43 vs. SRVEX (20.75).
SRVEXVITSXSRVEX / VITSX
Total Expense Ratio1.050.033,500%
Annual Report Gross Expense Ratio1.050.033,500%
Fund Existence37 years29 years-
Gain YTD10.00811.38788%
Front Load6%N/A-
Min. Initial Investment250050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets398M2.2T0%
Annual Yield % from dividends0.211.0120%
Returns for 1 year19.9928.2571%
Returns for 3 years40.2676.0453%
Returns for 5 years20.7572.4329%
Returns for 10 years50.95260.7520%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FTCI5.850.22
+3.91%
FTC Solar
GRAB3.60-0.01
-0.28%
Grab Holdings Limited
SHPH0.53-0.01
-1.43%
Shuttle Pharmaceuticals Holdings Inc
GYRE5.59-0.22
-3.79%
Gyre Therapeutics
NYAX68.80-4.83
-6.56%
Nayax Ltd